HKU Scholars Hub: Browsing DSpace

Browsing by Author Chiu, DKC

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 11 of 11

	Title	Author(s)	Issue Date	Views
	Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species Journal:Hepatology	Lee, D Zhang, MS Tsang, FHC Bao, MHR Xu, IMJ Lai, RKH Chiu, DKC Tse, APW Law, CT Chan, CYK Yuen, VWH Chui, NNQ Ng, IOL Wong, CM Wong, CCL	2021	21
	Assessment of Stabilization and Activity of the HIFs Important for Hypoxia-Induced Signalling in Cancer Cells Book:Cancer Metabolism: Methods and Protocols	Chiu, DKC Zhang, S Tse, PW Wong, CCL	2019
	Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer Journal:Cell Reports	Bao, MHR Yang, C Tse, APW Wei, L Lee, D Zhang, MS Goh, CC Chiu, DKC Yuen, WH Law, CT Chin, WC Chui, NNQ Wong, BPY Chan, CYK Ng, IOL Chung, CYS Wong, CM Wong, CCL	2021	35
	Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing Poliovirus Receptor and Inhibiting the Cytotoxic T-cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice Journal:Gastroenterology	Chiu, DKC Yuen, VWH Cheu, JWS Wei, LL Ting, V Fehlings, M Sumatoh, H Nardin, A Newell, EW Ng, IOL Yau, TCC Wong, CM Wong, CCL	2020	64
	Hypoxia inducible factor-1 (HIF-1)/ENTPD2 maintained hepatocellular carcinoma an immune-suppressive microenvironment Proceeding/Conference:International Liver Cancer Association (ILCA) Annual Conference	Chiu, DKC Tse, PW Wong, CM Ng, IOL Wong, CCL	2017
	Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway Journal:Cell Death & Disease	Chiu, DKC Tse, PW LAW, CT XU, JMJ LEE, D CHEN, M LAI, RKH YUEN, VWH CHEU, JWS Ho, DWH Wong, CM Zhang, H Ng, IOL Wong, CCL	2019
	Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development Journal:Science Advances	Cheu, JWS Chiu, DKC Kwan, KKL Yang, CX Yuen, VWH Goh, CC Chui, NNQ Shen, W Law, CT Li, QD Zhang, MS Bao, MHR Wong, BPY Chan, CYK Liu, CX Sit, GFW Ooi, ZY Deng, HJ Tse, APW Ng, IOL Wong, CCL	5-May-2023
	Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma Journal:Hepatology	Lee, D XU, IMJ CHIU, DKC Leibold, J Tse, APW Bao, MHR Yuen, VWH Chan, CYK LAI, RKH Chin, DWC Chan, DFF Cheung, TT Chok, SH Wong, CM Lowe, SW Ng, IOL Wong, CCL	2019	2
	Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD-L1 Journal:Hepatology Communications	Chui, NQN Cheu, JWS Yuen, VWH Chiu, DKC Goh, CC Lee, D Zhang, MS Ng, IOL Wong, CCL	2021
	Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis Journal:PLoS ONE	Wong, CCL Au, SLK Tse, APW Xu, IMJ Lai, RKH Chiu, DKC Wei, LL Fan, DNY Tsang, FHC Lo, RCL Wong, CM Ng, IOL	2014	115
	Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses Journal:International Journal of Hepatology	Yuen, VWH Chiu, DKC Law, CT Cheu, JWS Chan, CYK Wong, BPY Goh, CC Zhang, MS Xue, HDG Tse, APW Zhang, Y Lau, HYH Lee, DR Au-Yeung, RKH Wong, CM Wong, CCL	29-Nov-2022

Showing results 1 to 11 of 11